MD-CARE Act

The MD-CARE Act (Public Law 107-84) was designed to significantly expand federal research and public health efforts regarding various forms of muscular dystrophy, including Duchenne, myotonic, and facioscapulohumeral muscular dystrophy. The law required the National Institutes of Health (NIH) to establish specialized "Centers of Excellence" to accelerate medical breakthroughs and mandated the creation of a national coordinating committee to streamline research across federal agencies.

For citizens and families affected by these conditions, the Act aimed to improve quality of life by increasing funding for clinical trials, enhancing the collection of epidemiological data through the CDC, and establishing a national education program for healthcare professionals. By centralizing research and providing a formal mechanism for public input, the law sought to ensure that patients in both urban and underserved rural communities have better access to information, specialized care, and potential new treatments.